Utility of contrast-enhanced endoscopic ultrasound screening for pancreatic lesion, mainly pancreatic cancer of chronic pancreatitis. A prospective study.

Utility of contrast-enhanced endoscopic ultrasound screening for pancreatic lesion, mainly pancreatic cancer of chronic pancreatitis. A prospective study. - Utility of contrast-enhanced endoscopic ultrasound for screening of chronic pancreatitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032607

Enrollment

100

Registered

2018-05-16

Start date

2018-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pancreatitis, pancreatic cancer

Interventions

Perform pancreatic cancer screening for chronic pancreatitis patients with contrast-enhanced endoscopic ultrasound.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic pancreatitis diagnosed by clinical symptom, laboratory findings and imaging findings. Patients who can be performed surgery when pancreatic cancer is detected.

Exclusion criteria

Exclusion criteria: Patients who are pregnant or have a possibility of pregnancy. Patients who disagree informed consent. Patient judged by doctor as inappropriate as subject participant of study. Patients with egg allergy.

Design outcomes

Primary

Measure	Time frame
detection of pancreatic cancer	—

Countries

Japan

Contacts

Public ContactRyota Sagami

New Tokyo Hospital Department of Gastroenterology

sagami1985@yahoo.co.jp0477118700

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026